Logo image of GEMI

GEMINI SPACE STATION INC-A (GEMI) Stock Fundamental Analysis

USA - NASDAQ:GEMI - US36866J1051 - Common Stock

16.18 USD
+0.19 (+1.19%)
Last: 11/7/2025, 8:00:01 PM
16.2023 USD
+0.02 (+0.14%)
After Hours: 11/7/2025, 8:00:01 PM
Fundamental Rating

1

Taking everything into account, GEMI scores 1 out of 10 in our fundamental rating. GEMI was compared to 237 industry peers in the Capital Markets industry. Both the profitability and financial health of GEMI have multiple concerns. GEMI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GEMI had negative earnings in the past year.
In the past year GEMI has reported a negative cash flow from operations.
GEMI Yearly Net Income VS EBIT VS OCF VS FCFGEMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -100M -200M -300M

1.2 Ratios

GEMI has a Return On Assets of -25.41%. This is amonst the worse of the industry: GEMI underperforms 88.19% of its industry peers.
Industry RankSector Rank
ROA -25.41%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GEMI Yearly ROA, ROE, ROICGEMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 100 -100 200

1.3 Margins

GEMI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GEMI Yearly Profit, Operating, Gross MarginsGEMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 -100 -200 -300

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for GEMI remains at a similar level compared to 1 year ago.
GEMI has a worse debt/assets ratio than last year.
GEMI Yearly Shares OutstandingGEMI Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M 80M 100M
GEMI Yearly Total Debt VS Total AssetsGEMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 500M 1B 1.5B

2.2 Solvency

GEMI has an Altman-Z score of -1.25. This is a bad value and indicates that GEMI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.25, GEMI is doing worse than 84.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.25
ROIC/WACCN/A
WACCN/A
GEMI Yearly LT Debt VS Equity VS FCFGEMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 1.06 indicates that GEMI should not have too much problems paying its short term obligations.
GEMI has a Current ratio (1.06) which is in line with its industry peers.
GEMI has a Quick Ratio of 1.06. This is a normal value and indicates that GEMI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of GEMI (1.06) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
GEMI Yearly Current Assets VS Current LiabilitesGEMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for GEMI have decreased strongly by -67.98% in the last year.
Looking at the last year, GEMI shows a quite strong growth in Revenue. The Revenue has grown by 11.23% in the last year.
EPS 1Y (TTM)-67.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-375%
Revenue 1Y (TTM)11.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.04%

3.2 Future

The Earnings Per Share is expected to grow by 6.33% on average over the next years.
The Revenue is expected to grow by 54.04% on average over the next years. This is a very strong growth
EPS Next Y-180.2%
EPS Next 2Y-28%
EPS Next 3Y6.33%
EPS Next 5YN/A
Revenue Next Year23.99%
Revenue Next 2Y56.07%
Revenue Next 3Y54.04%
Revenue Next 5YN/A

3.3 Evolution

GEMI Yearly Revenue VS EstimatesGEMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
GEMI Yearly EPS VS EstimatesGEMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GEMI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GEMI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GEMI Price Earnings VS Forward Price EarningsGEMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GEMI Per share dataGEMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-28%
EPS Next 3Y6.33%

More info and screens

0

5. Dividend

5.1 Amount

GEMI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GEMINI SPACE STATION INC-A

NASDAQ:GEMI (11/7/2025, 8:00:01 PM)

After market: 16.2023 +0.02 (+0.14%)

16.18

+0.19 (+1.19%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)11-10 2025-11-10/amc
Inst Owners6.27%
Inst Owner ChangeN/A
Ins Owners7.77%
Ins Owner Change100%
Market Cap1.90B
Revenue(TTM)136.45M
Net Income(TTM)-399.65M
Analysts76.25
Price Target30.7 (89.74%)
Short Float %12.27%
Short Ratio1.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.92
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.41
EYN/A
EPS(NY)-2.21
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS1.16
BVpS-4.56
TBVpS-5.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -25.41%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.23%
Cap/Sales 4.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z -1.25
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-375%
EPS Next Y-180.2%
EPS Next 2Y-28%
EPS Next 3Y6.33%
EPS Next 5YN/A
Revenue 1Y (TTM)11.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.04%
Revenue Next Year23.99%
Revenue Next 2Y56.07%
Revenue Next 3Y54.04%
Revenue Next 5YN/A
EBIT growth 1Y28.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.44%
OCF growth 3YN/A
OCF growth 5YN/A

GEMINI SPACE STATION INC-A / GEMI FAQ

What is the ChartMill fundamental rating of GEMINI SPACE STATION INC-A (GEMI) stock?

ChartMill assigns a fundamental rating of 1 / 10 to GEMI.


Can you provide the valuation status for GEMINI SPACE STATION INC-A?

ChartMill assigns a valuation rating of 0 / 10 to GEMINI SPACE STATION INC-A (GEMI). This can be considered as Overvalued.


Can you provide the profitability details for GEMINI SPACE STATION INC-A?

GEMINI SPACE STATION INC-A (GEMI) has a profitability rating of 0 / 10.


Can you provide the financial health for GEMI stock?

The financial health rating of GEMINI SPACE STATION INC-A (GEMI) is 2 / 10.